Defining the Standard of Care for High-grade Glioma - a NICE Deal for UK Patients?

Clinical Oncology

Volumn 19, Issue 7, 2007, Pages 507-508

  Khanduri, S ^a   Gerrard, G ^a  

^a Northern and Yorkshire Clinical Trials and Research Unit   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; LOMUSTINE; PROCARBAZINE; TEMOZOLOMIDE; VINCRISTINE;

ADJUVANT THERAPY; ASTROCYTOMA; CANCER GRADING; CANCER SURVIVAL; CLINICAL TRIAL; DRUG INDICATION; EDITORIAL; GLIOBLASTOMA; GLIOMA; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HUMAN; NATIONAL HEALTH SERVICE; OLIGODENDROGLIOMA; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; TREATMENT PLANNING; UNITED KINGDOM;

ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DACARBAZINE; DELIVERY OF HEALTH CARE; GLIOMA; GREAT BRITAIN; HUMANS;

EID: 34547518006     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2007.05.004     Document Type: Editorial

References (8)

1. Stupp R., Mason W.P., Van Den Bent M.J., et al., On behalf of the European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials Group. Radiotherapy and concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352 (2005) 987-996
2. Walker M.D., Alexander E., Hunt W.E., et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 49 (1978) 333-343
3. Medical Research Council Brain Tumour Party. Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high grade astrocytoma: a Medical Research Council trial. J Clin Oncol 19 (2001) 509-518
4. Stewart L.A. Chemotherapy in adult high grade glioma. Lancet 359 (2002) 1011-1018
5. National Institute for Health and Clinical Excellence. Glioma (newly diagnosed and high grade) - carmustine implants and temozolomide. Technology Appraisal 2007.
6. Department of Health. The NHS Cancer Plan, 2001.
7. Saunders M.I., Dische S., Barrett A., Harvey A., Gibson D., Parmar M., et al. Continuous hyperfractionated accelerated radiotherapy (CHART). Lancet 350 (1997) 161-165
8. National Institute for Health and Clinical Excellence. Lung cancer - The diagnosis and treatment of lung cancer. February, 2005.